The organoids themselves recapitulated original tumour phenotypes, which were determined through immunohistological and immunofluorescence analyses targeting gene markers and the mutation of the tumour-suppressor protein p53, which is characteristic of the high-grade serous OCs investigated in this model. This evidence concerns the gene TP53 and neoplasm.